Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure

Chinese Journal of Cardiology

Volumn 40, Issue 2, 2012, Pages 141-146

  Peng, Yun Zhu ^a   Guo, Tao ^a   Yang, Ping ^b   Yang, Hong Wen ^b   Zhou, Ping ^b   Wang, Yu ^a   Luo, Zhi Ling ^a   Gu, Yun ^a   Pan, Jia Hua ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Extracorporeal cardiac shock wave therapy; Heart failure,congestive; Myocardial ischemia

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; EXTRACORPOREAL CARDIAC SHOCK WAVE THERAPY; EXTRACORPOREAL LITHOTRIPSY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERAPY EFFECT; TREATMENT OUTCOME;

AGED; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84862065612     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2012.02.013     Document Type: Article

References (13)

1. 2000, 28: 14-17.
2. Buszman P. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. Am J Cardiol, 2007, 99: 36-41.
3. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol, 2009, 53: e1-e90.
4. Pennel DJ, Ray SD, Dabies G, et al. The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study: methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure. Int J Cardiol, 2000, 72: 265-274.
5. Fu M, Sun CK, Lin YC, et al. Extracorporeal wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment. Plos One, 2011, 6: e24342.
6. Nishida T, Shimokawa H, Oi K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia induced myocardial dysfunction in pigs in vivo. Circulation, 2004, 110: 3055-3061.
7. Fukumoto Y, Ito A, Uwatoku T, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis, 2006, 17: 63-70.
8. Kikuchi Y, Ito K, Ito Y, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J, 2010, 74: 589-591.
9. 2010, 38: 711-716.
10. Yang H, Pu M, Rodriguez D, et al. Ischemic and viable myocardiumin patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography. J Am Coll Cardiol, 2004, 43: 592-598.
11. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation, 2008, 117: 103-114.
12. Zimpfer D, Aharinejad S, Holfeld J, et al. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thoracic Cardiovascular Surge, 2009, 137: 963-970.
13. Yury A, Vasyuk MD, Alla B, et al. Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congest Heart Fai, 2010, 16: 226-230.